Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
Häftad, Engelska, 2010
Av Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease, Institute of Medicine, Board on Health Sciences Policy, Food and Nutrition Board, Institute Of Medicine, Food And Nutrition Board, Board On Health Sciences Policy, Board On Health Care Services, Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Christine M. Micheel, John R. Ball, John R Ball, Christine M Micheel
929 kr
Tillfälligt slut
Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.
Produktinformation
- Utgivningsdatum2010-07-25
- Mått152 x 229 x 19 mm
- Vikt536 g
- FormatHäftad
- SpråkEngelska
- Antal sidor334
- FörlagNational Academies Press
- ISBN9780309151290